Notes
2016/2017 US dollars
Reference
Shahabi A, et al. Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants. PharmacoEconomics-Open : 17 Jul 2017. Available from: URL: http://dx.doi.org/10.1007/s41669-017-0042-3
Rights and permissions
About this article
Cite this article
Palivizumab in preterm infants: costs vary. PharmacoEcon Outcomes News 783, 27 (2017). https://doi.org/10.1007/s40274-017-4198-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4198-y